Kirk R. Schultz

University of British Columbia — Canada

Medicine · Health Sciences

70h-index21.6kcitations416works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(223), Acute Lymphoblastic Leukemia research(135), Immune Cell Function and Interaction(63), Childhood Cancer Survivors' Quality of Life(57), Acute Myeloid Leukemia Research(56)

Publications416 total

Investigating belumosudil in children with refractory moderate-to-severe chronic graft-versus-host disease: Design of a phase 1/2 study
Blood·2025
Murine regulatory NK cells restrict allogeneic CD4⁺ T cell-driven gvhd without compromising cytotoxic function
Blood·2025Open Access
Toward Better and More Effective Clinical Trials for Chronic Graft-Versus-Host Disease
Transplantation and Cellular Therapy·2025
Distinct biological subtypes of chronic GVHD after pediatric hematopoietic cell transplantation
Blood·2025· 2 citedOpen Access
Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort
Transplantation and Cellular Therapy·2025Open Access
Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group
Blood Advances·2025· 1 citedOpen Access
Corrigendum to Diagnosis of post-hematopoietic stem cell transplant bronchiolitis obliterans syndrome in children: time for a rethink? Transplantation and Cellular Therapy. 2024 Aug;30(8):760-769
Transplantation and Cellular Therapy·2025Open Access
Sinusoidal obstruction syndrome and other outcomes in pediatric patients with acute lymphoblastic leukemia who received inotuzumab ozogamicin before hematopoietic cell transplantation.
Journal of Clinical Oncology·2025
NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update
Transplantation and Cellular Therapy·2025· 2 citedOpen Access
Monitoring for paediatric pulmonary graft <i>versus</i> host disease with multiple breath washout
ERJ Open Research·2025Open Access
Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations
Leukemia·2025· 8 cited
Ask, do not tell: consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe
The Lancet Haematology·2025· 3 cited
Impact of Graft Versus Host Disease Following Allogeneic Hematopoietic Cell Transplantation on Leukemia Free Survival in Hematologic Malignancies: A CIBMTR Analysis
Transplantation and Cellular Therapy·2025
Human Regulatory-like Natural Killer Cells Associated with Chronic Graft-Versus-Host Disease Suppression Produce Regulatory Extracellular Vesicles.
Transplantation and Cellular Therapy·2025
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation
Transplantation and Cellular Therapy·2025· 1 cited
A Randomized Pilot Trial Comparing Anti-Thymocyte Globulin (ATG) with ATG Plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis Against Acute and Chronic Graft Versus Host Disease (GVHD) in Matched Donor Hematopoietic Cell Transplants (HCT)
Blood·2024
Five-Year Outcomes of the “Abatacept Combined with a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease (GVHD) Prophylaxis: A Randomized Controlled Trial” (‘ABA2‘)
Blood·2024Open Access
Impact of Extramedullary Disease on the Outcomes after Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Acute Myeloid Leukemia - a CIBMTR Analysis
Blood·2024
1011 Metabolic reprogramming alters natural killer cell responses in chronic graft-versus-host disease
Regular and Young Investigator Award Abstracts·2024Open Access
Expansion and characterization of immune suppressive CD56(bright)Perforin(-) regulatory-like natural killer cells in chronic graft-versus-host disease
Cytotherapy·2024· 5 citedOpen Access
page 1 of 21Next →

Frequent Co-authors

Stephanie J. Lee(17), Steven Z. Pavletic(15), Mary E.D. Flowers(13), Paul J. Martin(13), Georgia B. Vogelsang(11), Michael A. Pulsipher(8), Daniel R. Couriel(7), Michael J. Borowitz(7), Joseph Pidala(7), Daniel J. Weisdorf(6), Gèrard Socié(6), David A. Jacobsohn(6), Howard M. Shulman(6), Andrew J. Carroll(6), Nyla A. Heerema(6), William L. Carroll(6), Bruce M. Camitta(6), Corey Cutler(6), Robert Peter Gale(6), Meenakshi Devidas(5)